Assessing the Effect of Potential Reductions in Non-Hepatic Mortality on the Estimated Cost-Effectiveness of Hepatitis C Treatment in Early Stages of Liver Disease

作者:Leidner Andrew J; Chesson Harrell W; Spradling Philip R; Holmberg Scott D
来源:Applied Health Economics and Health Policy, 2017, 15(1): 65-74.
DOI:10.1007/s40258-016-0261-2